生物技術合作交易：2019-2025

《生物技術合作夥伴關係》深入了解並分析了公司如何以及為何達成合作協議。這份經過全面修訂和更新的報告提供了 2019 年至 2025 年合作協議的詳細資訊。

本報告提供雙方宣布的聯合研究協議的付款條款。這些數據為付款條款和其他貿易條款提供了寶貴的見解。

了解潛在合作夥伴談判交易條款的彈性可以為談判過程提供重要的見解，讓您了解談判條款時會發生什麼。許多中小企業可能會要求詳細的付款條款，但付款方式和權利轉讓方式的細節卻很重要。

本報告提供了當前協議交易和聯盟資料庫中記錄的自 2019 年以來宣布的聯盟的綜合列表，包括可用的財務條款，以及公司及其合作夥伴向 SEC 提交的實際聯盟協議文件的在線副本鏈接。

報告的第一章提供了合作交易和商業活動的指導。

第 1 章描述了本報告的介紹，第 2 章概述並分析了聯盟趨勢，並考慮了不同類型聯盟的好處。

第 3 章概述了合作協議的結構。

第 4 章回顧了 2019 年以來的主要合作交易。交易按總金額列出。如果交易與美國證券交易委員會 (SEC) 公佈了協議，則該連結可透過當前協議交易和合作夥伴關係資料庫在線存取該協議。

第 5 章提供了最活躍的 25 家合作夥伴製造商的綜合清單。每個交易標題都透過當前協議的交易和聯盟資料庫連結到完整交易記錄的線上版本，並在可用時連結到實際合約文件，從而可以輕鬆按需存取每個交易記錄。

第 6 章全面深入地回顧了自 2019 年以來達成或宣布的合作交易，並提供合約文件，按公司 A-Z、療法、技術和行業進行組織。合約文件詳細介紹了雙方就合作交易達成的實際條款和條件。

交易目錄包含自 2019 年以來宣布的所有合作研究交易的綜合清單。每個清單都按公司 A-Z、治療領域和技術類型組織成交易目錄。每個交易標題都透過超連結連結到交易記錄的線上版本，包括實際的合約文件（如果有）。

該報告還包含大量圖表和圖形，展示了 2019 年及以後的合作研究交易趨勢和活動。

目錄

摘要整理

第1章 簡介

第2章 聯盟交易趨勢

• 簡介
• 合作契約定義
• 2019年以後的聯盟交易趨勢
  • 聯盟交易的各年度轉變，2019年～2025年
  • 聯盟交易，2019年～2025年，各開發階段
  • 聯盟交易，2019年～2025年，各業界
  • 聯盟交易，2019年～2025年，各治療領域
  • 聯盟交易，2019年～2025年，各技術類型
  • 最活躍的各企業聯盟交易，2019年～2025年
• 簽訂聯盟契約的理由
• 合作契約的未來

第3章 合作契約結構概要

• 簡介
• 合作協定結構

第4章 主要聯盟交易

• 簡介
• 以價值為排名的頂級合作交易

第5章 最活躍的聯盟交易廠商主要25公司

• 簡介
• 最活躍的聯盟交易廠商主要25公司

第6章 -合作交易（含合約目錄）

• 簡介
• 2019 年至 2025 年期間簽訂的合作協議
• 貿易目錄
• 貿易目錄 - 按公司列出的業務合作夥伴清單 (AZ)
• 交易目錄 - 按治療領域劃分的合作交易
• 交易目錄 - 以技術類型劃分的合作交易
• 關於研究公司
• 當前合作夥伴關係
• 當前合約
• Current Partnering 的最新報告標題

Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals.

Fully revised and updated, the report provides details of collaboration deals from 2019 to 2025.

The report provides access to collaboration deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaboration contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of collaboration dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in collaboration as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of collaboration deals.

Chapter 4 provides a review of the leading collaboration deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active collaboration dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of collaboration deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

The deal directory includes a comprehensive listing of all collaboration deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in collaboration dealmaking since 2019.

In conclusion, this report provides everything a prospective dealmaker needs to know about collaboration alliances.

Key benefits

Collaboration Deals in Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse collaboration deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Collaboration Deals in Biotechnology is intended to provide the reader with an in-depth understanding of the collaboration trends and structure of deals entered into by leading biopharma companies worldwide.

Collaboration Deals in Biotechnology includes:

• Trends in collaboration dealmaking in the biotechnology industry
• Overview of collaboration deal structure
• Directory of collaboration deal records covering biotechnology and biotechnology
• The leading collaboration deals by value
• Most active collaboration dealmakers
• The leading collaboration partnering resources

In Collaboration Deals in Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Collaboration Deals in Biotechnology provides comprehensive access to available records for collaboration deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What subcollaboration and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2019
  • 2.3.1. Collaboration dealmaking by year, 2019-2025
  • 2.3.2. Collaboration dealmaking by phase of development, 2019-2025
  • 2.3.3. Collaboration dealmaking by industry sector, 2019-2025
  • 2.3.4. Collaboration dealmaking by therapy area, 2019-2025
  • 2.3.5. Collaboration dealmaking by technology type, 2019-2025
  • 2.3.6. Collaboration dealmaking by most active company, 2019-2025
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts 2019-2025
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deal
• Figure 2: Trends in collaboration deal announcements, 2019-2025
• Figure 3: Collaboration deals signed at each phase of development, 2019-2025
• Figure 4: Collaboration deals by industry sector, 2019-2025
• Figure 5: Collaboration deals by therapy area, 2019-2025
• Figure 6: Collaboration deals by technology type, 2019-2025
• Figure 7: Top 25 most active collaboration dealmakers, 2019-2025
• Figure 8: Top collaboration deals by value, 2019-2025
• Figure 9: Most active collaboration dealmakers, 2019-2025